Center for Transfusion Medicine and Cellular Therapies, Emory University School of Medicine, Atlanta, Georgia, USA.
Joint Program in Transfusion Medicine, Department of Pathology, Brigham and Women's Hospital, Boston, Massachusetts, USA.
Transfusion. 2023 Mar;63(3):457-462. doi: 10.1111/trf.17251. Epub 2023 Jan 27.
The impact of blood storage on red blood cell (RBC) alloimmunization remains controversial, with some studies suggesting enhancement of RBC-induced alloantibody production and others failing to observe any impact of storage on alloantibody formation. Since evaluation of storage on RBC alloimmunization in patients has examined antibody formation against a broad range of alloantigens, it remains possible that different clinical outcomes reflect a variable impact of storage on alloimmunization to specific antigens.
RBCs expressing two distinct model antigens, HEL-OVA-Duffy (HOD) and KEL, separately or together (HOD × KEL), were stored for 0, 8, or 14 days, followed by detection of antigen levels prior to transfusion. Transfused donor RBC survival was assessed within 24 h of transfusion, while IgM and IgG antibody production were assessed 5 and 14 days after transfusion.
Stored HOD or KEL RBCs retained similar HEL or KEL antigen levels, respectively, as fresh RBCs, but did exhibit enhanced RBC clearance with increased storage age. Storage enhanced IgG antibody formation against HOD, while the oppositive outcome occurred following transfusion of stored KEL RBCs. The distinct impact of storage on HOD or KEL alloimmunization did not appear to reflect intrinsic differences between HOD or KEL RBCs, as transfusion of stored HOD × KEL RBCs resulted in increased IgG anti-HOD antibody development and reduced IgG anti-KEL antibody formation.
These data demonstrate a dichotomous impact of storage on immunization to distinct RBC antigens, offering a possible explanation for inconsistent clinical experience and the need for additional studies on the relationship between RBC storage and alloimmunization.
血液储存对红细胞(RBC)同种免疫的影响仍存在争议,一些研究表明储存增强了 RBC 诱导的同种抗体产生,而另一些研究则未能观察到储存对同种抗体形成的任何影响。由于评估患者储存对 RBC 同种免疫的影响检查了针对广泛同种抗原的抗体形成,因此仍然有可能不同的临床结果反映了储存对特定抗原同种免疫的不同影响。
分别或同时表达两种不同模型抗原(HEL-OVA-Duffy[HOD]和 KEL)的 RBC 分别储存 0、8 或 14 天,然后在输血前检测抗原水平。输血后 24 小时内评估供体 RBC 的存活情况,而 IgM 和 IgG 抗体产生则在输血后 5 和 14 天评估。
储存的 HOD 或 KEL RBC 分别保留了与新鲜 RBC 相似的 HEL 或 KEL 抗原水平,但随着储存年龄的增加,表现出增强的 RBC 清除率。储存增强了针对 HOD 的 IgG 抗体形成,而储存 KEL RBC 输血后的结果则相反。储存对 HOD 或 KEL 同种免疫的不同影响似乎并不反映 HOD 或 KEL RBC 之间的内在差异,因为输注储存的 HOD×KEL RBC 导致 IgG 抗-HOD 抗体的产生增加和 IgG 抗-KEL 抗体的形成减少。
这些数据表明储存对不同 RBC 抗原免疫的影响存在二分法,为临床经验不一致和对 RBC 储存与同种免疫关系的进一步研究提供了可能的解释。